The Role of Nuclear Factor-κB in Cytokine Gene Regulation

American Journal of Respiratory Cell and Molecular Biology

Volumn 17, Issue 1, 1997, Pages 3-9

  Blackwell, Timothy S ^a   Christman, John W ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE; MOUSE MUTANT; NEUTROPHIL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROMOTER REGION; REVIEW; SEPSIS;

ADULT; ANIMALS; CYTOKINES; FEEDBACK; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEUTROPHILS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; TRANSCRIPTION, GENETIC;

EID: 0031183766     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.17.1.f132     Document Type: Review

References (44)

1. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
2. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
3. Miyamoto, S., and I. M. Verma. 1995. REL/NF-κB/IκB story. Adv. Cancer Res. 66:255-287.
4. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and funclion of NF-κB. Annu. Rev. Cell. Biol. 10:405-455.
5. Schmitz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO. J. 10:3805.
6. Brockman, J. A., D. C. Scherer, S. M. Hall, T. A. McKinsey, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal-response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
7. Chen, Z., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitin-dependent protein kinase activity. Cell 84:853-862.
8. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
9. Orian, A., S. Whiteside, A. Israel, I. Stancovski, A. L. Schwartz, and A. Ciechanover. 1995. Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105. J. Biol. Chem. 270:21707-21714.
10. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87: 13-20.
11. Mukaida, N., A. Hishinuma, C. O. C. Zachariae, J. J. Oppenheim, and K. Matsushima. 1991. Regulation of human interleukin 8 gene expression and binding of several other members of the intercrine family to receptors for interleukin-8. In Chemotactic Chemokines, J. Westwick, et al., editors. Plenum Press, New York. 31-38.
12. Akira, S., and T. Kishimoto. 1992. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol. Rev. 127:25-50.
13. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91:752-756.
14. Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
15. Lin, R., D. Gewert, and J. Hiscott. 1995. Differential transcriptional activation in vitro by NF-κB/Rel proteins. J. Biol. Chem. 270:3123-3131.
16. Jongeneel, C. V. 1994. Regulation of the TNF alpha gene. Prog. Clin. Biol. Res. 388:367-381.
17. Lin, G., A. E. Pearson, R. W. Scamurra, Y. Zhou, M. J. Baarsch, D. J. Weiss, and M. P. Murtaugh. 1994. Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide. J. Biol. Chem. 269:77-85.
18. Ito, C. Y., A. G. Kazantsev, and A. S. Baldwin, Jr. 1994. Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha. Nucleic Acids Res. 22:3787-3792.
19. Cogswell, P. C., R. I. Scheinman, and A. S. Baldwin, Jr. 1993. Promoter of the NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-RE-L. J. Immunol. 150:2794-27804.
20. Ziegler-Heitbrock, H. W. L., A. Wedel, W. Schraut, M. Strobel, P. Wedelgass, T. Sternsdorf, P. Bauerle, J. G. Haas, G. Riethmuller. 1994. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J. Biol. Chem. 269:17001-17004.
21. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M Biillah. 1995. Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes. J. Biol. Chem. 270:9558-9563.
22. Schwartz, M. D., E. E. Moore, F. A. Moore, R. Shenkar, P. Moine, J. B. Haenel, and E. Abraham. 1996. Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit. Care Med. 24:1285-1292.
23. Miller, E. J., A. B. Cohen, S. Nagao, D. Griffith, R. J. Maunder, T. R. Martin, J. P. Weiner-Kronish, M. Sticherling, E. Christophers, and M. A. Matthay. 1992. Elevated levels of NAP-1/interleukin-8 are present in the air-spaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146:427-432.
24. Hyers, T. M., S. M. Tricomi, P. A. Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144:268-271.
25. Asahara, H., M. Asanuma, N. Ogawa, S. Nishibayashi, and H. Inoue. 1995. High DNA-binding activity of transcription factor NF-κB in synovial membranes of patients with rheumatoid arthritis. Biochem. Mol. Biol. Int. 37:827-832.
26. Blackwell, T. S., E. P. Holden, T. R. Blackwell, J. E. DeLarco, and J. W. Christman. 1994. Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: association with nuclear factor kappa B. Am. J. Respir. Cell Mol. Biol. 11:464-472.
27. Blackwell, T. S., E. P. Holden, T. R. Blackwell, B. W. Christman, and J. W. Christman. 1996. Activation of NF-κB in rat lungs by treatment with endotoxin: modulation by treatment with N-acetylcysteine. J. Immunol. 157: 1630-1637.
28. Shenkar, R., M. D. Schwartz, L. S. Terada, J. E. Repine, J. McCord, and E. Abraham. 1996. Hemorrhage activates NF-kappa-B in murine lung mononuclear cells in vivo. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 14:L729-L735.
29. Haddad, E. B., M. Salmon, H. Koto, P. J. Barnes, I. Adcock, and K. F. Chung. 1996. Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-kappa B in rat lung: inhibition by corticosteroids. FEBS Lett. 379:265-268.
30. Kaltschmidt, C., B. Kaltschmidt, J. Lannes-Vieira, G.W. Kreutzberg, H. Wekerle, P. A. Baeuerle, and J. Gehrmann. 1994. Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis. Prog. Clin. Biol. Res. 388:367-181.
31. Neurath, M. F., S. Pettersson, K. H. Meyer zum Buschenfelde, and W. Strober. 1996. Local administration of antisense phosphorothiotate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nature Med. 2:998-1004.
32. Sakurai, H., Y. Hisada, M. Ueno, M. Sugiura, K. Kawashima, and T. Sugita. 1996. Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochem. Biophys. Acta 1316:132-138.
33. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170.
34. Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736-2746.
35. Klement, J. F., N. R. Rice, B. D. Car, S. J. Abbondanzo, G. D. Powers, H. Bhatt, C. H. Chen, C. A. Rosen, and C. L. Stewart. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341-2349.
36. Sha, W. C., H. C. Liou, E. I. Toumanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune response. Cell 80:321-330.
37. Kontgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarliinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
38. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-340.
39. Schmidt-Ullrich, R., S. Memet, A. Lilienbaum, J. Feuillard, M. Raphael, and A. Israel. 1996. NF-kappa B activity in transgenic mice: developmental regulation and tissue specificity. Development 122:2117-2128.
40. Schreck, R. K., K. Alberman, and P. A. Baeuerle. 1992. Nuclear factor κB: an oxidative stress-response transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17:221-237.
41. Mirochnitchenko, O., and M. Inouye. 1996. Effect of overexpression of human Cu,Zn superoxide dismutase in transgenic mice on macrophage functions. J. Immunol. 156:1578-1586.
42. Schmidt, K. N., P. Amstad, P. Cerutti, and P. A. Baeuerle. 1995. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem. Biol. 2:13-22.
43. Scheinman, R. L. P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
44. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.